{
    "answer": "Cosentyx's immunology segment net sales (Q4 2024): USD 2,087 million (reported, +25%, +16% cc), with full year 2024 reported net sales: USD 3,741 million (+9.74%), and full year 2024 constant currency net sales: USD 3,698 million (+25.06%).",
    "ground_truth": "$6,141,000,000; 23% increase (reported); 25% increase (constant currency)",
    "rewards": [
        0,
        0,
        0,
        0,
        0,
        0
    ],
    "reward_sum": 0,
    "turns": 6,
    "search count": 4,
    "script count": 0,
    "summary count": 0,
    "context lengths": [
        866,
        2338,
        3902,
        5344,
        6467,
        7046
    ]
}